2020
DOI: 10.3390/biomimetics6010001
|View full text |Cite
|
Sign up to set email alerts
|

Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization

Abstract: Drug development is a decades-long, multibillion dollar investment that often limits itself. To decrease the time to drug approval, efforts are focused on drug targets and drug formulation for optimal biocompatibility and efficacy. X-ray structural characterization approaches have catalyzed the drug discovery and design process. Single crystal X-ray diffraction (SCXRD) reveals important structural details and molecular interactions for the manifestation of a disease or for therapeutic effect. Powder X-ray diff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
4

Year Published

2021
2021
2025
2025

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(11 citation statements)
references
References 126 publications
0
7
0
4
Order By: Relevance
“…It can also incorporate some methods like standard addition, internal standard, and reference internal ratio (RIR), combined with peak and background fitting, integral and Rietveld refinement calculations, to determine the amorphous content in the sample relative to the total crystalline phase content. However, recent uses of synchrotron have allowed wider investigations in the field of amorphous or poorly-crystalline solids [44].…”
Section: Phase Identification and Quantificationmentioning
confidence: 99%
“…It can also incorporate some methods like standard addition, internal standard, and reference internal ratio (RIR), combined with peak and background fitting, integral and Rietveld refinement calculations, to determine the amorphous content in the sample relative to the total crystalline phase content. However, recent uses of synchrotron have allowed wider investigations in the field of amorphous or poorly-crystalline solids [44].…”
Section: Phase Identification and Quantificationmentioning
confidence: 99%
“…XRD has been used for the identification of the crystalline state of 5-FU and the possible interaction of the drug with four lipids [49,50]. XRD peak depends on crystal size because the crystalline nature of the drug was detected at a certain value at the 2θ range [51].…”
Section: Pre-formulation Studies With Excipientsmentioning
confidence: 99%
“…On the other hand, the non-destructive nature of XRD and FTIR spectroscopic methods makes them ideal tools for systematic drug-excipient compatibility assessment in the pre-formulation studies. It is well known that the percent of crystallinity can influence a drug's processing behaviour as well as its pharmacological performance [13,28], being related to its solubility and dissolution [2,36]. Additionally, the vibrational changes detected by FTIR method serve as direct evidence for potential intermolecular interactions among the dosage components.…”
Section: Ft-ir Spectroscopymentioning
confidence: 99%